{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:13Z","timestamp":1790629753774,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"the University of Science and Technology of Hanoi, Vietnam"},{"name":"The Institut des Humanit\u00e9s de Paris, France"},{"name":"the National Center for Scientific Research, France"},{"name":"the University Paris Diderot, Paris"},{"name":"ANR, France"},{"name":"CGI, France"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bioorg.2018.10.033","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:53:14Z","timestamp":1540007594000},"page":"180-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis"],"prefix":"10.1016","volume":"83","author":[{"given":"Thi Huyen","family":"Vu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0954-9193","authenticated-orcid":false,"given":"Nguyet-Thanh","family":"Ha-Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-4793","authenticated-orcid":false,"given":"Alexandra","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Capton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-3387","authenticated-orcid":false,"given":"Pierre","family":"Fechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pl\u00e9siat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-1209","authenticated-orcid":false,"given":"Nawal","family":"Serradji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.10.033_b0005","unstructured":"Geneva: WHO guidelines for the treatment of Chlamydia trachomatis, 2016."},{"issue":"4","key":"10.1016\/j.bioorg.2018.10.033_b0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1258\/ijsa.2010.010385","article-title":"The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study","volume":"22","author":"Venkatesh","year":"2011","journal-title":"Int. J. STD AIDS"},{"issue":"2","key":"10.1016\/j.bioorg.2018.10.033_b0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0956462414531243","article-title":"Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000\u20132011","volume":"26","author":"Peterman","year":"2015","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.bioorg.2018.10.033_b0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-9378-9-30","article-title":"High prevalence of hpv multiple genotypes in women with persistent Chlamydia trachomatis infection","volume":"9","author":"Seraceni","year":"2014","journal-title":"Infect. Agent Cancer"},{"issue":"10","key":"10.1016\/j.bioorg.2018.10.033_b0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cam4.496","article-title":"Medical microbiological laboratories and the CSI group. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection","volume":"4","author":"Vriend","year":"2015","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.bioorg.2018.10.033_b0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bjo.2008.148494","article-title":"Trachoma: global magnitude of a preventable cause of blindness","volume":"93","author":"Mariotti","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.bioorg.2018.10.033_b0035","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1021\/jm960436i","article-title":"Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida","volume":"40","author":"McFarland","year":"1997","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2018.10.033_b0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0966-842X(00)01854-0","article-title":"Obligate intracellular bacteria and antibiotic resistance","volume":"8","author":"McOrist","year":"2000","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.bioorg.2018.10.033_b0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0732-8893(01)00221-8","article-title":"In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines","volume":"39","author":"Samra","year":"2001","journal-title":"Diagn. Microbiol. Infect Dis."},{"issue":"9","key":"10.1016\/j.bioorg.2018.10.033_b0050","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/fmb.10.96","article-title":"Antibiotic resistance in Chlamydiae","volume":"5","author":"Sandoz","year":"2010","journal-title":"Future Microbiol."},{"issue":"4","key":"10.1016\/j.bioorg.2018.10.033_b0055","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/IAI.72.4.1843-1855.2004","article-title":"Chlamydial persistence: beyond the biphasic paradigm","volume":"72","author":"Hogan","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bioorg.2018.10.033_b0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/sextrans-2011-050385","article-title":"Azithromycin antimicrobial resistance and genital. Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy","volume":"88","author":"Horner","year":"2012","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.bioorg.2018.10.033_b0065","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.2741\/hahn","article-title":"Chlamydia pneumoniae as a respiratory pathogen","volume":"7","author":"Hahn","year":"2002","journal-title":"Front. Biosci."},{"issue":"7","key":"10.1016\/j.bioorg.2018.10.033_b0070","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/IAI.00023-07","article-title":"Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron","volume":"75","author":"Slepenkin","year":"2007","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.bioorg.2018.10.033_b0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijantimicag.2010.03.018","article-title":"Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"36","author":"Chu","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.bioorg.2018.10.033_b0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ja.2012.43","article-title":"Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion","volume":"65","author":"Ur-Rehman","year":"2012","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"16","key":"10.1016\/j.bioorg.2018.10.033_b0085","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/j.bmcl.2014.06.056","article-title":"Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors","volume":"24","author":"Abdelsayed","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.10.033_b0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejmech.2015.07.019","article-title":"Design, synthesis and evaluation of novel polypharmacological antichlamydial agents","volume":"101","author":"Sunduru","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.033_b0095","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/ja00008a028","article-title":"Spectroscopic studies of the electronic structure of iron(III) tris(catecholates)","volume":"113","author":"Karpishin","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.10.033_b0100","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1021\/ja00143a021","article-title":"O-TRENSOX: a promising water-soluble iron chelator (Both FeIII and FeII) potentially suitable for plant nutrition and iron chelation therapy","volume":"117","author":"Baret","year":"1995","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.bioorg.2018.10.033_b0105","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1016\/j.bmcl.2012.03.096","article-title":"Derivatives of 8-hydroxyquinoline-antibacterial agents that target intra- and extracellular Gram-negative pathogens","volume":"22","author":"Enquist","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.10.033_b0110","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmc.2014.05.067","article-title":"Synthesis and antibacterial activity of catecholate-ciprofloxacin conjugates","volume":"22","author":"Fardeau","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.033_b0115","doi-asserted-by":"crossref","first-page":"e83511","DOI":"10.1371\/journal.pone.0083511","article-title":"Penicillin kills Chlamydia following the fusion of bacteria with lysosomes and prevents genital inflammatory lesions in C. muridarum-infected mice","volume":"8","author":"Dumoux","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bioorg.2018.10.033_b0120","first-page":"173","article-title":"In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum","volume":"3","author":"Rumpianesi","year":"1984","journal-title":"Chemioterapia"},{"key":"10.1016\/j.bioorg.2018.10.033_b0125","unstructured":"Chemdrawbio Ultra version 13.0.03015."},{"key":"10.1016\/j.bioorg.2018.10.033_b0130","series-title":"Chlamydia","first-page":"9","article-title":"Genomic autobiographies of Chlamydiae","author":"Stephens","year":"1999"},{"issue":"5","key":"10.1016\/j.bioorg.2018.10.033_b0135","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/AAC.49.5.1787-1793.2005","article-title":"Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis","volume":"49","author":"Reveneau","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bioorg.2018.10.033_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/0929867321666141011194624","article-title":"Chemistry and biology of pyoverdines, Pseudomonas primary siderophores","volume":"22","author":"C\u00e9zard","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2018.10.033_b0145","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity","volume":"48","author":"Aubry","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.bioorg.2018.10.033_b0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1462-5822.2002.00191.x","article-title":"Determination of the physical environment within the Chlamydia trachomatis inclusion using ion-selective ratiometric probes","volume":"4","author":"Grieshaber","year":"2002","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.bioorg.2018.10.033_b0155","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/AAC.43.5.1129","article-title":"Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones","volume":"43","author":"Pan","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2018.10.033_b0160","unstructured":"Clinical and Laboratory Standards Institute (CLSI, USA). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard Mo7-A10."},{"key":"10.1016\/j.bioorg.2018.10.033_b0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1432-1033.1994.tb19028.x","article-title":"The mechanism of iron release from transferrin. Slow-proton-transfer-induced loss of nitrilotriacetatoiron(III) complex in acidic media","volume":"223","author":"Chahine","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2018.10.033_b0170","unstructured":"R.A. Binstead, A.D. Zuberb\u00fchler, B. Jung, Specfit Global Analysis System Version 3.0.34, 2003."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818305819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818305819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:45:21Z","timestamp":1758613521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818305819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":34,"alternative-id":["S0045206818305819"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.033","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}